Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Girard Gibbs LLP
Girard Gibbs LLP Investigates Possible Securities Laws Violations Concerning Schering-Plough Corp., Inc.
March 8th, 2008
Girard Gibbs LLP is investigating an alleged securities fraud by Schering-Plough Corp., Inc. ("Schering-Plough") and certain of its executives between July 24, 2006 and January 14, 2008. It is alleged that Schering-Plough issued a series of material misrepresentations in its filings with the Securities and Exchange Commission and press releases which artificially inflated the value of Schering-Plough shares. It is alleged that Schering-Plough misled investors regarding the increased efficacy of Vytorin, a combination of Zetia and Zocor, over the cheaper generic form of Zocor (simvastatin), alone, and delayed disclosing results of the ENHANCE...
Source: Law & Health Weekly (2008-03-08)
|
